Steven Carl Quay"Steven Carl Quay is a physician-scientist and founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics for the prevention and treatment of breast cancer.
He receive his M.D., M.S., and Ph.D. from The University of Michigan, was a postdoctoral fellow at the Massachusetts Institute of Technology with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-Massachusetts General Hospital, a facility member of Harvard Medical School, and was on the faculty of Stanford University School of Medicine for a decade. His 390+ scientific contributions to medicine have been cited over 12,000 times, placing him in the top 1% of scientists worldwide.
He is the author of two Amazon Best Seller books related to the COVID-19 Pandemic and has testified before the US Congress on medical research and healthcare national policy issues, as well as advised the US State Department on complex medical questions related to national security.
He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 91 US patents for inventions in 22 different fields of medicine. The medicines he has invented have been used by over 80 million people worldwide. His current passion is the prevention of the two million yearly breast cancer cases worldwide. A TEDx talk he delivered on breast cancer prevention has been viewed over 220,000 times. He is now a senior fellow at the Hudson Institute with a portfolio including National Security and the Confluence of Artificial Intelligence and Synthetic Biology. For more information, visit www.DrQuay.com or follow him on X (formerly Twitter) at @quay_dr." Read More Read Less